Global Pulmonary Arterial Hypertension Market Size study, by Drugs Class (Prostacyclin and Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonist (ERA), Phosphodiesterase 5 (PDE-5)), and Regional Forecasts 2021-2027
- BIZ4618041
- 200 Pages
- August 2021
- Medical Devices
Global Pulmonary Arterial Hypertension Market is valued approximately at USD 5.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.9% over the forecast period 2021-2027. Pulmonary Arterial Hypertension is a kind of high blood pressure which affects arteries in the lungs area and cause heart related problems. The global Pulmonary Arterial Hypertension market is being driven by rising incidents of Pulmonary Arterial Hypertension (PAH) and growing geriatric population. Furthermore, the government support for development of orphan drugs will provide new opportunities for the global Pulmonary Arterial Hypertension industry. For instance, according to the study of an American College of Cardiology, in year 2020, the incidence rate of COVID-19 infection in PAH patients was 2.1 cases per 1,000 patients. This increased the demand for PAH drugs for its treatment to manage the risk of COVID-19 infection. As a result, increased in PAH patients and related diseases will serve as a catalyst for the Pulmonary Arterial Hypertension industry in the future. However, patent expiration of key molecules may impede market growth over the forecast period of 2021-2027. Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global Patent Expiration of Key Molecules market. The improving healthcare systems and rapid economic developments as well as large population base makes Asia Pacific the leading region across the world in terms of market share. Whereas Asia pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to high burden of diseases, such as HIV and diabetes in the region. Major market player included in this report are: Johnson & Johnson Services, Inc Gilead Sciences, Inc. United Therapeutics Corporation Acceleron Pharma, Inc. GlaxoSmithKline Plc. (GSK) Pfizer, Inc. Bayer AG Novartis International AG Dong-A ST Co., Ltd. Merck Sharp & Dohme Corp. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Drugs Class: Prostacyclin and Prostacyclin Analogs Soluble Guanylate Cyclase (SGC) Stimulators Endothelin Receptor Antagonist (ERA) Phosphodiesterase 5 (PDE-5) By Region: North America U.S. Canada Europe UK Germany France Spain Italy ROE Asia Pacific China India Japan Australia South Korea RoAPAC Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year – 2018, 2019 Base year – 2020 Forecast period – 2021 to 2027. Target Audience of the Global Pulmonary Arterial Hypertension Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion) 1.2.1. Pulmonary Arterial Hypertension Market , by Region, 2019-2027 (USD Billion) 1.2.2. Pulmonary Arterial Hypertension Market , by Drug Class, 2019-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Pulmonary Arterial Hypertension Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Pulmonary Arterial Hypertension Market Dynamics 3.1. Pulmonary Arterial Hypertension Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 3.1.1.1. Rising incidents of Pulmonary Arterial Hypertension (PAH) 3.1.1.2. Growing geriatric population 3.1.2. Market Restraint 3.1.2.1. Patent expiration of key molecules 3.1.3. Market Opportunities 3.1.3.1. Government support for development of orphan drugs Chapter 4. Global Pulmonary Arterial Hypertension Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Pulmonary Arterial Hypertension Market , by Drug Class 5.1. Market Snapshot 5.2. Global Pulmonary Arterial Hypertension Market by Drug Class, Performance - Potential Analysis 5.3. Global Pulmonary Arterial Hypertension Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion) 5.4. Pulmonary Arterial Hypertension Market , Sub Segment Analysis 5.4.1. Prostacyclin And Prostacyclin Analogs 5.4.2. Soluble Guanylate Cyclase (SGC) Stimulators 5.4.3. Endothelin Receptor Antagonist (ERA) 5.4.4. Phosphodiesterase 5 (PDE-5) Chapter 6. Global Pulmonary Arterial Hypertension Market , Regional Analysis 6.1. Pulmonary Arterial Hypertension Market , Regional Market Snapshot 6.2. North America Pulmonary Arterial Hypertension Market 6.2.1. U.S. Pulmonary Arterial Hypertension Market 6.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027 6.2.2. Canada Pulmonary Arterial Hypertension Market 6.3. Europe Pulmonary Arterial Hypertension Market Snapshot 6.3.1. U.K. Pulmonary Arterial Hypertension Market 6.3.2. Germany Pulmonary Arterial Hypertension Market 6.3.3. France Pulmonary Arterial Hypertension Market 6.3.4. Spain Pulmonary Arterial Hypertension Market 6.3.5. Italy Pulmonary Arterial Hypertension Market 6.3.6. Rest of Europe Pulmonary Arterial Hypertension Market 6.4. Asia-Pacific Pulmonary Arterial Hypertension Market Snapshot 6.4.1. China Pulmonary Arterial Hypertension Market 6.4.2. India Pulmonary Arterial Hypertension Market 6.4.3. Japan Pulmonary Arterial Hypertension Market 6.4.4. Australia Pulmonary Arterial Hypertension Market 6.4.5. South Korea Pulmonary Arterial Hypertension Market 6.4.6. Rest of Asia Pacific Pulmonary Arterial Hypertension Market 6.5. Latin America Pulmonary Arterial Hypertension Market Snapshot 6.5.1. Brazil Pulmonary Arterial Hypertension Market 6.5.2. Mexico Pulmonary Arterial Hypertension Market 6.6. Rest of The World Pulmonary Arterial Hypertension Market Chapter 7. Competitive Intelligence 7.1. Top Market Strategies 7.2. Company Profiles 7.2.1. Johnson & Johnson Services, Inc. 7.2.1.1. Key Information 7.2.1.2. Overview 7.2.1.3. Financial (Subject to Data Availability) 7.2.1.4. Product Summary 7.2.1.5. Recent Developments 7.2.2. Gilead Sciences, Inc. 7.2.3. United Therapeutics Corporation 7.2.4. Acceleron Pharma, Inc. 7.2.5. GlaxoSmithKline Plc. (GSK) 7.2.6. Pfizer, Inc. 7.2.7. Bayer AG 7.2.8. Novartis International AG 7.2.9. Dong-A ST Co., Ltd. 7.2.10. Merck Sharp & Dohme Corp. Chapter 8. Research Process 8.1. Research Process 8.1.1. Data Mining 8.1.2. Analysis 8.1.3. Market Estimation 8.1.4. Validation 8.1.5. Publishing 8.2. Research Attributes 8.3. Research Assumption
List of Tables TABLE 1. Global Pulmonary Arterial Hypertension Market , report scope TABLE 2. Global Pulmonary Arterial Hypertension Market estimates & forecasts by region 2018-2027 (USD Billion) TABLE 3. Global Pulmonary Arterial Hypertension Market estimates & forecasts by Drug Class 2018-2027 (USD Billion) TABLE 4. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 5. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 6. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 7. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 8. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 9. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 10. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 11. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 12. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 13. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 14. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 15. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 16. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 17. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 18. Global Pulmonary Arterial Hypertension Market by segment, estimates & forecasts, 2018-2027 (USD Billion) TABLE 19. Global Pulmonary Arterial Hypertension Market by region, estimates & forecasts, 2018-2027 (USD Billion) TABLE 20. U.S. Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 21. U.S. Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 22. U.S. Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 23. Canada Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 24. Canada Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 25. Canada Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 26. UK Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 27. UK Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 28. UK Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 29. Germany Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 30. Germany Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 31. Germany Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 32. France Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 33. France Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 34. France Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 35. Spain Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 36. Spain Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 37. Spain Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 38. Italy Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 39. Italy Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 40. Italy Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 41. ROE Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 42. ROE Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 43. ROE Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 44. China Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 45. China Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 46. China Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 47. India Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 48. India Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 49. India Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 50. Japan Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 51. Japan Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 52. Japan Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 53. Australia Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 54. Australia Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 55. Australia Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 56. South Korea Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 57. South Korea Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 58. South Korea Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 59. ROPAC Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 60. ROPAC Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 61. ROPAC Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 62. Brazil Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 63. Brazil Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 64. Brazil Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 65. Mexico Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 66. Mexico Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 67. Mexico Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 68. ROLA Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 69. ROLA Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 70. ROLA Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 71. ROW Pulmonary Arterial Hypertension Market estimates & forecasts, 2018-2027 (USD Billion) TABLE 72. ROW Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 73. ROW Pulmonary Arterial Hypertension Market estimates & forecasts by segment 2018-2027 (USD Billion) TABLE 74. List of secondary sources used in the study of global Pulmonary Arterial Hypertension Market . TABLE 75. List of primary sources used in the study of global Pulmonary Arterial Hypertension Market . TABLE 76. Years considered for the study. TABLE 77. Exchange rates considered.
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
